Replies to post #287732 on NorthWest Biotherapeutics Inc (NWBO)

[longfellow95]

Seems like nobody knows...
Lol.

Cognate completed their management buyout in Feb 2018.

Cognate BioServices, a leading contract development and manufacturing organization (“CDMO”) in the global cellular therapies industry, announced today it has completed a management buyout (“MBO”) and raised capital from a group of global investment firms including Santa Monica, Calif.-based Tennenbaum Capital Partners, LLC (“TCP”), Medivate Partners and affiliates (“Medivate”) based in Seoul, South Korea and a sovereign wealth fund.

https://www.cognatebioservices.com/cognate-completes-management-buyout-raises-growth-capital-fund-commercial-cellular-therapy-manufacturing-expansion/


The previous owner was Toucan. Or at least the principal owner. And LP has a continuing interest in Toucan, as far as we know. But beyond that it's a bit muddy. Toucan runs various dated funds, and periodically pays out to its own investors, when a fund reaches maturity. I've no idea if (or by how much) LP would have personally benefited from the sale of Cognate to its own management.

Oh yes. Advent was spun out of Cognate, before the management buyout. So Advent is owned by Toucan, in which LP has an interest.